ask="20.75"
ask_size="300"
average_daily_volume="183115"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="+0.05"
change_from_200_day_moving_average="3.86"
change_from_50_day_moving_average="-0.31"
change_from_52_week_high="-3.55"
change_From_52_week_low="8.40"
change_in_percent="+0.24%"
close="20.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18634000"
high="21.00"
high_52_weeks="24.30"
last_trade_date="2/8/2017"
last_trade_price="20.75"
last_trade_size="10269"
last_trade_time="4:00pm"
low="20.40"
low_52_weeks="12.35"
market_capitalization="591.69M"
moving_average_200_day="16.89"
moving_average_50_day="21.06"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="20.50"
pe_ratio="N/A"
peg_ratio="-0.59"
percent_change_from_200_day_moving_average="+22.88%"
percent_change_from_50_day_moving_average="-1.49%"
percent_change_from_52_week_high="-14.61%"
percent_change_from_52_week_low="+68.02%"
previous_close="20.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.94"
price_per_sales="1967.54"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.14"
stock_exchange="NGM"
symbol="RVNC"
volume="155381"
weeks_range_52="12.35 - 24.30"
